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Abstract
Background/purpose While endoscopic sphincterotomy
(EST) is performed worldwide for the removal of common
bile duct stones, many biliary endoscopists hesitate to
regard endoscopic papillary balloon dilation (EPBD) as a
standard procedure for treatment. Therefore, the aim of this
review is to re-evaluate the status of EPBD for the treat-
ment of common bile duct stones.
Results A major beneﬁt of EPBD is preservation of pap-
illaryfunction,whichisnotcompletebutmaybegreaterthan
that after EST. The disadvantages of EPBD compared with
ESTarethatEPBDisdifﬁculttousefortheremovaloflarger
stones because of the smaller biliary opening, it requires
more frequent use of mechanical lithotripsy, and it is asso-
ciated with a higher incidence of pancreatitis, although the
risks of bleeding and perforation are low. Since the biliary
sphincteriseasilydilatedwithaballooncatheter,EPBDmay
be effective for patients with anatomic anomalies, such as
after gastric bypass surgery or in the presence of a periam-
pullarydiverticulum.Nostandardprocedureexiststoreduce
the risk of acute pancreatitis with EPBD.
Conclusion EPBD is feasible, however, we must pursue
less hazardous techniques of papillary balloon dilation.
Furthermore, we must understand the beneﬁts and limita-
tions of EPBD and determine whether it could provide
clinical beneﬁts for long-term complications.
Keywords Endoscopic papillary balloon dilation 
Endoscopic sphincterotomy  Common bile duct stones
Introduction
Endoscopic sphincterotomy (EST) was developed by
Classen and Demling [1], Kawai and colleagues [2], and
Sohma and colleagues [3] in 1973 for the non-surgical
therapy of common bile duct stones, and has been widely
accepted as an effective procedure. Many studies have
demonstrated the therapeutic beneﬁts of EST [4–6]. How-
ever, EST also has negative aspects, including early dan-
gerous complications such as bleeding, perforation, and
permanent loss of sphincter function. Endoscopic papillary
balloon dilation (EPBD) has been advocated as an alter-
native treatment to EST, with possible advantages. EPBD
is easier to perform than EST, and does not have the short-
term complications of bleeding and perforation. Further-
more, preserving the biliary sphincter may result in a
decrease in long-term complications. However, several
concerns exist with EPBD, such as the difﬁculty of
removing larger stones because of the smaller biliary
opening, the more frequent need for mechanical lithotripsy,
and the higher incidence of pancreatitis after the procedure,
compared with EST [7–10]. Some endoscopists believe
that EPBD will become the standard treatment of choice
for bile duct stones; others do not share this point of view.
The aim of this review is to re-evaluate the current status
of EPBD for the treatment of common bile duct stones. In
addition, less hazardous techniques of papillary balloon
dilation which avoid complications such as pancreatitis are
discussed.
Historical background of EPBD
EST carries an 8–12% risk of early complications, such as
bleeding, duodenal perforation, and pancreatitis [5, 11, 12].
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Staritz and colleagues in 1983 [13] as a less traumatic
procedure. They originally used a special balloon catheter,
which was 15 mm in diameter with a banana shape, in 15
patients for the treatment of biliary diseases including
common bile duct stones and found that no complications
occurred. Although little attention was paid to EPBD due
to the high incidence of acute pancreatitis [14, 15], it was
subsequently re-evaluated by May and colleagues in 1993
[16], and by MacMathuna and coworkers [17, 18] in 1994
and 1995. These US reports showed that EPBD was a safe
and effective alternative to EST for the management of
small bile duct stones and that the incidence of post-EPBD
pancreatitis was similar to that with EST. Moreover, in
1997 in Europe, Bergman and colleagues assessed the
outcome of 101 patients with common bile duct stones
treated with EPBD or EST in a prospective randomized
controlled trial [19]. They concluded that the success rate
of EPBD was similar to that of EST, with no difference in
the rate of early complications, including pancreatitis,
suggesting that EPBD may be a valuable alternative to EST
in patients with common bile duct stones. Komatsu and
colleagues [20] also reported preferable outcomes of EPBD
in 226 Japanese patients with common bile duct stones in
1998. From these results, it appeared that the use of EPBD
had spread broadly throughout the world. However, one
international multicenter trial caused hesitation regarding
the use of EPBD because of an increased risk of post-
procedure pancreatitis [21, 22]. DiSario and coworkers
reported in 2004 that the incidence of severe complica-
tions, including pancreatitis, was signiﬁcantly higher in the
EPBD group than that in the EST group, and that there
were two deaths due to pancreatitis after papillary balloon
dilation and none with EST [8]. In addition, multivariate
analysis showed balloon dilation to be the only factor
signiﬁcantly associated with morbidity [23]. Thus, EPBD is
regarded as a risky procedure, and has largely been aban-
doned in routine clinical practice by US endoscopists. In
contrast, EPBD is still a popular procedure for the removal
of common bile duct stones in parts of Europe, Korea, and
Japan.
Advantages and disadvantages of EPBD
One of the major potential advantages of EPBD over EST
is the preservation of papillary sphincter function [24–27].
EST permanently destroys the function of the biliary
sphincter by cutting it, leading to duodenobiliary reﬂux
which can cause long-term complications, such as cho-
langitis, recurrent stones [28–31], and the possibility of
malignant transformation of the choledochal epithelium
[31]. In contrast, EPBD is expected to restore papillary
function, because the sphincter of Oddi is dilated by
inﬂation of a balloon, which appears to be less hazardous to
the papilla of Vater. MacMathuna and colleagues [32]
studied histopathological changes after papillary balloon
dilation using a porcine model, and revealed that papillary
balloon dilation caused neither smooth muscle disruption
nor ﬁbrosis, and no alteration of papillary architecture.
Manometric studies indicated at least partial recovery of
papillary function 1 month after EPBD [24], although
transient papillary dysfunction occurred 1 week after
EPBD [24, 27]. Manometric studies also demonstrated that
papillary function at 1 year was improved compared with
that at 1 week, but still remained signiﬁcantly lower than
function before EPBD, suggesting that although preserva-
tion of papillary function after EPBD was not complete, it
was greater than that after EST [27]. Interestingly, EPBD
does not adversely affect gallbladder motility in the long
term (5 years), based on results of a study of gallbladder
volumes determined by ultrasonography [25]. In response
to these ﬁndings, it is necessary to continue to investigate
further clinical beneﬁts for long-term complications.
On the basis of preservation of papillary function, EPBD
is an attractive option, especially in young patients with
common bile duct stones. However, it is not that simple
because the rate of post-procedural pancreatitis could be
higher with EPBD than with EST. Thus, we must identify
the limitations as well as the potential advantages of
EPBD.
Several randomized controlled trials have compared the
success rates of stone removal and the frequency of early
complications of EPBD with EST. Weinberg and
coworkers [33] performed a meta-analysis of the results of
ﬁfteen randomized clinical trials comparing EPBD and
EST for the removal of common bile duct stones by
searching the Cochrane Library, MEDLINE, and EMBASE
up to January 2004. According to this meta-analysis, EPBD
is statistically less successful for stone removal, requires
higher rates of mechanical lithotripsy, and carries a higher
risk of pancreatitis. Interestingly, the subgroup analysis
showed that the pancreatitis risk is higher for patients
\60 years of age in the EPBD group. In contrast, while no
signiﬁcant difference was found in the rates of perforation,
bleeding occurred signiﬁcantly less frequently with EPBD,
suggesting that EPBD may be preferable in patients with
coagulopathy. Furthermore, EPBD causes signiﬁcantly
fewer short-term and long-term infections, suggesting that
EPBD should be the preferred strategy in patients who are
at risk for infection. Although there was no statistically
signiﬁcant difference between EPBD and EST with regard
to overall mortality, the authors concluded that EPBD
seemed to play a clinical role, possibly greater in older
patients rather than in young people, in the risk of death
from pancreatitis.
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catheter, EPBD could be a safe and effective technique for
the treatment of patients with anatomical anomalies such as
those due to gastric bypass surgery or in the presence of a
periampullary diverticulum [34–36]. Bergman and col-
leagues conducted a randomized trial of EPBD and EST for
the treatment of common bile duct stones in patients with a
prior Billroth II gastrectomy [36]. The study showed that
EPBD was easier to perform than EST in these patients, the
risk of bleeding was virtually absent, and the risk of pan-
creatitis was not signiﬁcantly increased.
Consideration of safer techniques for EPBD
The opening of the bile duct and the pancreatic duct is
surrounded by a complex arrangement of smooth muscle
collectively called the sphincter of Oddi, which comprises
the sphincter choledochus, sphincter pancreaticus, sphincter
ampullae, and fasciculus longitudinalis. In most cases, the
meshwork of muscle ﬁbers around the ampulla of Vater at
the level of the oral protrusion inside the muscle layer of the
duodenum and at the level passing through the wall of the
duodenum is dense and thick (Fig. 1). However, at the level
proximal to the junction with the pancreatic duct outside the
duodenal wall, smooth muscle of common bile duct gen-
erally becomes rough and thin, and partly disappears
(Fig. 2). Balloon dilation seemed theoretically less haz-
ardous. However, it is possible that the inﬂammatory edema
caused by the inﬂated balloon compresses the sphincter
around the pancreatic duct, inducing obstructive pancrea-
titis. Alternatively, it is possible that the thin and weak
smooth muscle around the common bile duct could tear
when the balloon is inﬂated within the bile duct, leading to
Fig. 1 Normal histology of the sphincter of Oddi at the oral protrusion
inside the muscle layer of the duodenum. a The bile duct and the
pancreatic duct are close together and are surrounded by the dense and
thick sphincter of Oddi. Ab portion of the bile duct, Ap portion of the
pancreatic duct, mp muscle of the duodenum. b Image of the papillary
balloon dilation at the level of the portion of the bile duct inside the
muscle layer of the duodenum. A blue and translucent circle, 8 mm in
diameter, represents the maximal inﬂation of the balloon
Fig. 2 Normal histology of the sphincter of Oddi at the portion of the
bile duct outside the duodenal wall. a The bile duct is surrounded by
the rough and thin sphincter of Oddi, which has partly disappeared on
the side of the parenchyma of the pancreas. Ab portion of the bile
duct, mp muscle of the duodenum. b Image of the papillary balloon
dilation at the portion of the bile duct outside the duodenal wall. A
blue and translucent circle, 8 mm in diameter, represents the maximal
inﬂation of the balloon
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123the leakage of bile into the parenchyma of the pancreas,
which could also cause pancreatitis. We must avoid trauma
to the sphincter and pancreatic oriﬁce as much as possible.
Therefore, we must pursue safe techniques to reduce the
risk of acute pancreatitis with EPBD. Unfortunately, there is
no standard technique for EPBD. Table 1 shows the diam-
eters of the dilation balloons, maximum pressure, length of
time of balloon inﬂation, and number of times the balloon
was inﬂated described in various studies of EPBD for the
removal of common bile duct stones, sorted in order of the
incidence of post-EPBD pancreatitis. EPBD procedures
vary, as shown in Table 1, and the relationship between the
incidence of pancreatitis and the EPBD maneuvers seems to
be extremely indistinct. Tsujino and coworkers showed
statistically signiﬁcant risk factors for post-EPBD pancre-
atitis using univariate and multivariate analysis [39].
Although age, periampullary diverticulum, pancreatic duct
opaciﬁcation, dilation balloon diameter, dilation pressure
and dilation time were statistically signiﬁcant by univariate
analysis, only pancreatic duct opaciﬁcation was a signiﬁ-
cant risk factor for post-EPBD pancreatitis by multivariate
analysis. Furthermore, they evaluated efﬁcacy and safety of
their recent modiﬁed dilation methods, in which the balloon
was inﬂated slowly (0.5 atmospheres per approximately
15 s) until disappearance of the balloon waist, and the
pressure was then maintained for 15 s, compared with the
initial method, in which the balloon was gradually
(approximately 1 min) inﬂated to 8 atmospheres for 2 min.
The results showed that the incidence of post-procedural
pancreatitis tended to be lower in the modiﬁed group than in
the initial group, and that the severity of pancreatitis was
signiﬁcantly reduced in the modiﬁed group. These ﬁndings
indicate that lower pressure and shorter duration of dilation
is less traumatic to the papilla, resulting in fewer compli-
cations. In addition, Nakagawa and colleagues also inves-
tigated the risk factors for acute pancreatitis after EPBD
[38]. They described two cases of acute pancreatitis after
EPBD in whom the inﬂation pressure needed for disap-
pearance of the notch sign (i.e., the balloon waist) was over
5 atmospheres. The study concluded that poor function of
the minor duodenal papilla, high inﬂation pressure required
for disappearance of the notch sign, severe abdominal pain,
Table 1 EPBD procedures associated with post-EPBD pancreatitis
References Pancreatitis (%) Balloon
diameter
(mm)
Maximum
pressure of
inﬂation
balloon (atm)
Length of time (process) of
balloon inﬂation
Number of times
balloon inﬂated
Ochi et al. [37] 0.0 8 8 Inﬂated for 60 s and reinﬂated a further two
times at 60 s intervals
3
Nakagawa and Ohara [38] 1.0 8 Notch Gradually inﬂated in a period 2 min and
immediately deﬂated
1
Tsujino et al. [39] 4.0 8, 6, 4 Notch Slowly inﬂated at 0.5 atm per 15 s and
maintained for 15 s
1
Vlavianos et al. [40] 4.8 10 12 Inﬂated to a pressure of 12 atm for 30 s Repeated until
satisfactory
Natsui et al. [41] 5.7 8 8 Inﬂated at a pressure of 8 atm for 2 min 1
Yasuda et al. [27] 5.7 8 6 Inﬂated twice and each inﬂation lasted for
1 min at 6 atm
2
Sugiyama et al. [42] 6.0 8 nd Inﬂated to a diameter of 8 mm for 2 min 1
Bergman et al. [19] 6.9 8 Notch Inﬂated over 1–2 min and maintained for 45–60 s 1
Tsujino et al. [39] 7.4 8, 6, 4 8 Gradually (approximately 1 min) inﬂated
with 8 atm for 2 min
1
Minami et al. [43] 10.0 8 nd Inﬂated within 3 min to 15–20 psi 1
Fujita et al. [44] 10.9 8, 6, 4 Notch Expanded slowly over a period of nearly
3 min and kept for 15 s
1
DiSario et al. [8] 15.4 8 or less nd Dilated to 8 mm or the maximum size of the
duct and inﬂated for 1 min
1
Watanabe et al. [10] 16.7 8 7 Inﬂated up to 8 mm in diameter at a pressure
of 7 atm for 2 min
1
Tanaka et al. [45] 18.7 8 8 Inﬂated to 8 atm for 2 min 1
Arnold et al. [46] 20.0 8 10 Inﬂated to a diameter of 8 mm for 60 s and
repeated for additional 60 s
2
EPBD endoscopic papillary balloon dilation, Ref references, nd not described, Notch pressure needed for disappearance of the notch sign
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123and a lengthy procedure increased the risk of post-EPBD
pancreatitis. If it is true that high pressure of the inﬂation
balloon required for disappearance of the notch sign is
associated with the occurrence of acute pancreatitis, we
must stop dilating the balloon in the papilla of Vater, and
change to papillary sphincterotomy when the notch sign
does not disappear at a high inﬂation pressure, at most over
5 atmospheres. Since the commercially available balloons
for EPBD are generally made from polyethylene tere-
phthalate or nylon, they start to dilate rapidly at low pres-
sure, and the size of the balloon reaches more than 90% of
the fully inﬂated balloon diameter, even at a low inﬂation
pressure of 0.5 atmospheres. EPBD with gradual inﬂation of
the balloon may be very important for decreasing the risk of
trauma to the sphincter of Oddi, especially during the ﬁrst
0–2 atmospheres of inﬂation. The speed of balloon inﬂation
within the sphincter of Oddi may be the most important
factor for safe EPBD.
Furthermore, we should note that the inﬂation pressure
required for disappearance of the notch sign is not always
equal to the maximum pressure of the inﬂation balloon
which yields the maximum diameter of the balloon. The
diameter of the inﬂation balloon is usually maximal at 8–12
atmospheres, dependent on the manufacturer and type. The
balloon must be inﬂated to the maximum pressure to obtain
its maximum diameter. Unfortunately, it is not known how
long the maximum pressure should be maintained within
the sphincter or the number of times balloon dilation
should be repeated for safe and efﬁcient EPBD.
In addition, another way to avoid pancreatitis may be to
select the optimal balloon diameter, which should be
smaller than the diameter of the common bile duct to
prevent trauma to the sphincter and pancreatic oriﬁce. In
addition to the key roles of balloon dilation, concerns still
exist about the size and number of stones in EPBD.
Although patients with large common bile duct stones, of a
size exceeding the diameter of the papillary oriﬁce after
EPBD, frequently require additional treatment, such as
mechanical lithotripsy, to achieve ductal clearance, EPBD
appears to be an appropriate treatment for small bile duct
stones. In patients with 3 or less bile duct stones\10 mm,
EPBD of the biliary sphincter to a diameter of 8 mm is
nearly always successful without the need for additional
EST or mechanical lithotripsy and without a signiﬁcant
difference in the incidence of post-procedure pancreatitis
from that after EST [47]. Randomized controlled trials
comparing EPBD with EST suggest that EPBD is at least
as effective as EST in patients with small-to-moderate-
sized bile duct stones [48]. Based on the results of the
JESED study group, patients with common bile duct stones
14 mm or less in maximum shorter diameter on radio-
graphic images can be treated with either EST or EPBD
with the same success rate for stone clearance and fre-
quency of complications [44].
Recent issues in EPBD
One of the major limitations of EPBD, unlike EST, is the
difﬁculty of removing larger stones because the biliary
opening is not enlarged sufﬁciently. In comparative stud-
ies, mechanical lithotripsy was used more frequently in the
EPBD group than in the EST group [33, 48]. An additional
EST after EPBD was also required in 10–19% of patients
who underwent papillary balloon dilation [33]. In 2003,
Ersoz and coworkers reported that EST followed by
sequential EPBD using a 12– 20-mm diameter balloon may
be effective for difﬁcult removal of large bile duct stones
(more than 15 mm) and/or barrel-shaped stones, or in
patients with tapering of the distal common bile duct; the
rate of early complications, such as mild cholangitis (3%),
mild pancreatitis (3%), and mild-to-moderate bleeding
(9%), was acceptable [49]. After that report, the efﬁcacy
and safety of large size balloon dilation of the biliary ori-
ﬁce after biliary sphincterotomy by another endoscopist
was evaluated in the management of difﬁcult-to-extract
bile duct stones in several studies (Table 2). Although the
extent of sphincterotomy varies among these studies,
ranging from limited to extended, success rates and com-
plication rates after EST combined with EPBD may be
Table 2 Outcome of EST followed by EPBD for treatment of choledocholithiasis
References Country n Extent of EST Balloon diameter
(mm)
Overall success
rate (%)
Success rate in
the ﬁrst session (%)
Complications
(%)
Ersoz et al. [49] Turkey 58 Large 12–20 100 82.9 15.5
Bang et al. [50] Korea 22 Limited 10–15 100 72.7 4.5
Minami et al. [51] Japan 88 Small 20 98.9 98.9 4.5
Heo et al. [52] Korea 100 Minor (1/3) 12–20 97.0 83.0 5.0
Attasaranya et al. [53] USA 103 Initial or extended 12–18 nd 95.0 5.4
Kochhar et al. [54] India 74 Limited 10, 12, 15, 18 91.9 83.8 21.6
Itoi et al. [55] Japan 53 2/3B 15, 18, 20 100 96.0 4.0
EST endoscopic sphincterotomy, EPBD endoscopic papillary balloon dilation, Ref references, nd not described
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123acceptable [49–57]. Interestingly, it is likely that complete
stone removal in the ﬁrst session would be accomplished at
higher rates with EST plus EPBD with a large size balloon
than with EST alone. The degree of sphincterotomy before
EPBD remains to be determined. We need to establish
whether small sphincterotomy with large size balloon
dilation could lead to late complications, such as stricture
of the biliary oriﬁce.
Conclusions
EPBD has been performed in many patients for the treat-
ment of common bile duct stones all over the world,
especially in parts of Asia and Europe, and most patients
have beneﬁtted from it. Unfortunately, no standard proce-
dure for safe EPBD has been established. Thus, we must
work to understand the beneﬁts and limitations of EPBD,
and to determine the theoretical and practical safe proce-
dures of EPBD in order to make it an alternative to EST.
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